Addex Therapeutics Ltd (ADXN) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Addex Therapeutics Ltd (ADXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $7.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 2.00 to the broader market. Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Led by Timothy Mark Dyer, public since 2020-02-12.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for ADXN as of 2026-08-23; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →